MAP3K12 anticorps (AA 101-400) (HRP)
Aperçu rapide pour MAP3K12 anticorps (AA 101-400) (HRP) (ABIN7160024)
Antigène
Voir toutes MAP3K12 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 101-400
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Mitogen-activated protein kinase kinase kinase 12 protein (101-400AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- MAP3K12 (Mitogen-Activated Protein Kinase Kinase Kinase 12 (MAP3K12))
-
Autre désignation
- MAP3K12
-
Sujet
-
Background: May be an activator of the JNK/SAPK pathway. Phosphorylates beta-casein, histone 1 and myelin basic protein in vitro.
Aliases: Dlk antibody, Dual leucine zipper bearing kinase antibody, Dual leucine zipper kinase DLK antibody, Leucine-zipper protein kinase antibody, M3K12_HUMAN antibody, Map3k12 antibody, MAPK-upstream kinase antibody, MEKK12 antibody, Mitogen-activated protein kinase kinase kinase 12 antibody, Mixed lineage kinase antibody, MUK antibody, Protein kinase MUK antibody, ZPK antibody, ZPKP1 antibody
-
UniProt
- Q12852
-
Pathways
- Signalisation MAPK
Antigène
-